Evidence map›Paper›PMID 33313664›Full record

ArticleEuropean heart journal2021

Coronavirus disease 2019 in adults with congenital heart disease: a position paper from the ESC working group of adult congenital heart disease, and the International Society for Adult Congenital Heart Disease.

Gerhard-Paul Diller, Michael A Gatzoulis, Craig S Broberg, Jamil Aboulhosn, Margarita Brida, Markus Schwerzmann, Massimo Chessa, Adrienne H Kovacs, Jolien Roos-Hesselink

Open access · bronzeAbstract readConsensus Statement
In one paragraph

Article in European heart journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. A novelExperimental and therapeutic medicine · 2022
    Article
  13. Article
  14. The impact of Covid-19 on cardiovascular health.Nursing in critical care · 2022
    Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 8 institutions in 8 countries.

Gerhard-Paul DillerDepartment of Cardiology III - Adult Congenital and Valvular Heart Disease, University Hospital Muenster, Albert-Schweitzer Campus 1, Muenster, Germany.ORCID 0000-0003-3050-5248
Michael A GatzoulisAdult Congenital Heart Centre and National Centre for Pulmonary Arterial Hypertension, Royal Brompton and Harefield NHS Trust, Sydney Street, SW3 6NP London, UK.
Craig S BrobergKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Jamil AboulhosnAhmanson/UCLA Adult Congenital Heart Center, 100 UCLA Medical Plaza, Suite 630 East, Los Angeles, CA 90095, USA.
Margarita BridaSchool of Cardiovascular Medicine & Sciences, Kings College, WC2R 2LS London, UK.ORCID 0000-0001-8754-8156
Markus SchwerzmannCenter of Congenital Heart Disease, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.ORCID 0000-0002-4006-8929
Massimo ChessaACHD Unit, Pediatric and Adult Congenital Heart Centre, IRCCS-Policlinico San Donato, Piazza Edmondo Malan, 2, 20097 San Donato Milanese MI, Italy.
Adrienne H KovacsKnight Cardiovascular Institute, Oregon Health & Science University, Portland, OR, USA.
Jolien Roos-HesselinkACHD Unit, Erasmus Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.ORCID 0000-0002-6770-3830
Oregon Health & Science University · USAristotle University of Thessaloniki · GRErasmus MC · NLIRCCS Policlinico San Donato · ITUCLA Medical Center · USUniversity Hospital Centre Zagreb · HRUniversity Hospital Münster · DEUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We are witnessing an unparalleled pandemic caused by the novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) associated with coronavirus disease 2019 (COVID-19). Current data show that SARS-CoV-2 results in mild flu-like symptoms in the majority of healthy and young patients affected. Nevertheless, the severity of COVID-19 respiratory syndrome and the risk of adverse or catastrophic outcomes are increased in patients with pre-existing cardiovascular disease. Patients with adult congenital heart disease (ACHD)-by definition-have underlying cardiovascular disease. Many patients with ACHD are also afflicted with residual haemodynamic lesions such as valve dysfunction, diminished ventricular function, arrhythmias or cyanosis, have extracardiac comorbidities, and face additional challenges regarding pregnancy. Currently, there are emerging data of the effect of COVID-19 on ACHD patients, but many aspects, especially risk stratification and treatment considerations, remain unclear. In this article, we aim to discuss the broad impact of COVID-19 on ACHD patients, focusing specifically on pathophysiology, risk stratification for work, self-isolation, hospitalization, impact on pregnancy, psychosocial health, and longer-term implications for the provision of ACHD care.

Indexed as

Cardiovascular DiseasesCOVID-19Heart Defects, CongenitalAdultHumansPandemicsSARS-CoV-2Adult congenital heart diseaseCoronaCOVID-19Position paperSARS-CoV-2

Identifiers

PMID33313664
PMCPMC7799120
OpenAlexW3113049899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.